Elsevier

Vaccine

Volume 20, Issues 13–14, 15 March 2002, Pages 1831-1836
Vaccine

A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community

https://doi.org/10.1016/S0264-410X(02)00041-5Get rights and content

Abstract

Aim: To estimate the effectiveness of inactivated influenza vaccine in persons aged 65 years and over living in the community. Scope: A meta-analysis of studies selected using predetermined criteria without language restriction. Conclusion: Influenza vaccine was effective in reducing influenza-like illness by 35% (95% confidence interval (CI) 19–47%), hospitalization for pneumonia and influenza by 33% (CI 27–38%), mortality following hospitalization for pneumonia and influenza by 47% (CI 25–62%); and mortality from all causes by 50% (CI 45–56%).

Introduction

Although influenza affects all age groups, persons with underlying medical conditions and persons aged 65 years and over are at greatest risk of severe illness and possibly death [1], [2]. As recommended by the World Health Organization, the major strategy for controlling influenza is annual immunization of those at greatest risk with an inactivated influenza vaccine [3].

However, published studies on influenza vaccine effectiveness (VE) have produced inconsistent results. The only randomized double-blind placebo-controlled trial, conducted in The Netherlands in the 1991–1992 influenza season, found that the vaccine reduced serologically-confirmed influenza by 50% (95% CI 39–65%) [4]. However, the reduction was only 23% (95% CI 51–61%) in persons 70 years of age and over. One cohort and two case-control studies have reported low estimates of VE with wide confidence intervals, including the possibility that the vaccine had no effect [5], [6], [7].

A previously published meta-analysis of influenza VE in the elderly concentrated largely on residents of nursing homes [8]. The only meta-analysis of influenza VE in persons aged 65 years and over living in the community is a Spanish language publication [9] limited to one influenza-related outcome. With the aim of estimating influenza VE for all major influenza-related outcomes for persons aged 65 years and over living in the community, we performed a comprehensive and systematic review of the available literature and a meta-analysis on studies that satisfied specified inclusion and exclusion criteria.

Section snippets

Methods

We followed guidelines for preparing systematic reviews and meta-analyses, using multiple sources of information without language restriction [10], [11], [12]. The cut-off date for the literature search was the 31 December 2000. Differences in the effectiveness of whole virion, subunit virion and split virion vaccines were outside the scope of this study. Additionally, we excluded studies examining differences between single and multiple vaccinations, influenza vaccine immunogenicity or

Studies included in the meta-analysis

Database and website searches identified 49 relevant publications, including 12 publications in languages other than English. Of the latter group, six satisfied the inclusion/exclusion criteria and were translated by qualified translators [9], [17], [18], [19], [20], [21]. No additional publications or unpublished studies were identified by manual searches or by the two prominent researchers in the field.

We excluded 34 of the 49 publications. Table 3 summarizes nine studies excluded for reasons

Discussion

Results of this meta-analysis confirm that the influenza vaccine is effective in reducing influenza-related illness and death among persons 65 years and over living in the community. When there is a good match between influenza strains in the vaccine and those in circulation, vaccination would prevent approximately one in five cases of influenza-like illness, one in four hospitalizations for pneumonia and influenza and one in four deaths following hospitalization for these conditions. These

Acknowledgements

We would like to thank Dr. J.S. Nguyen-Van-Tam from the University of Nottingham and Dr. Kristin L. Nichol from the Veterans Affairs Medical Center (Minneapolis) for their comments on the bibliography. We are indebted also to Mr. Shigeru Takahashi and Ms. Qui Nguyen for their translation of a study written in Japanese, and to Dr. David Fairservice for his translation of Spanish and Italian articles. We thank Julianne Lynch for her helpful suggestions during the preparation of the manuscript.

References (41)

  • Berlin BS. Influenza. In: Youmans GP, Paterson PY, Sommers HM, editors. The biologic and clinical basis of infectious...
  • T.M. Govaert et al.

    The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

    JAMA

    (1994)
  • Barker W, Raubertas R, Menegus M, O’Brien D, Freundlich C, Betts R. Case-control study of influenza vaccine...
  • Strikas R, Cook P, Kuller L, et al. Case-control study in Ohio and Pennsylvania on prevention of hospitalisation by...
  • A.H. Ahmed et al.

    Effectiveness of influenza vaccine in reducing hospital admissions during the 1989–1990 epidemic

    Epidemiol. Infect.

    (1997)
  • A. Gross et al.

    The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature

    Ann. Intern. Med.

    (1995)
  • J. Puig-Barbera et al.

    Effectiveness of influenza vaccine in the elderly: a critical review of the bibliography (Spanish)

    Med. Clin. (Barc)

    (1995)
  • Cochrane Collaboration. The Cochrane Manual, Version 9904. July...
  • Petitti DB. Meta-analysis. Decision analysis, and cost-effectiveness analysis methods for quantitative synthesis in...
  • NHS Center for Reviews and Dissemination (CRD). Undertaking Systematic Reviews of Research on Effectiveness. CRD...
  • Cited by (0)

    1

    Tel.: +1-613-83447276; fax: +1-613-93476136.

    2

    Tel.: +1-613-93422608; fax: +1-613-93422665.

    View full text